BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12009407)

  • 1. The importance of cysteine 126 in the human liver UDP-glucuronosyltransferase UGT1A6.
    Senay C; Jedlitschky G; Terrier N; Burchell B; Magdalou J; Fournel-Gigleux S
    Biochim Biophys Acta; 2002 May; 1597(1):90-6. PubMed ID: 12009407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoaffinity labeling of the aglycon binding site of the recombinant human liver UDP-glucuronosyltransferase UGT1A6 with 7-azido-4-methylcoumarin.
    Senay C; Battaglia E; Chen G; Breton R; Fournel-Gigleux S; Magdalou J; Radominska-Pandya A
    Arch Biochem Biophys; 1999 Aug; 368(1):75-84. PubMed ID: 10415114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of histidine residues for the function of the human liver UDP-glucuronosyltransferase UGT1A6: evidence for the catalytic role of histidine 370.
    Ouzzine M; Antonio L; Burchell B; Netter P; Fournel-Gigleux S; Magdalou J
    Mol Pharmacol; 2000 Dec; 58(6):1609-15. PubMed ID: 11093802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of glucuronidation through reduction of a disulfide bond in rat UDP-glucuronosyltransferase 1A6.
    Ikushiro S; Emi Y; Iyanagi T
    Biochemistry; 2002 Oct; 41(42):12813-20. PubMed ID: 12379124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The streptococcal hyaluronan synthases are inhibited by sulfhydryl-modifying reagents, but conserved cysteine residues are not essential for enzyme function.
    Kumari K; Tlapak-Simmons VL; Baggenstoss BA; Weigel PH
    J Biol Chem; 2002 Apr; 277(16):13943-51. PubMed ID: 11799120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of aspartic acid and histidine residues mediating the reaction mechanism and the substrate specificity of the human UDP-glucuronosyltransferases 1A.
    Li D; Fournel-Gigleux S; Barré L; Mulliert G; Netter P; Magdalou J; Ouzzine M
    J Biol Chem; 2007 Dec; 282(50):36514-24. PubMed ID: 17956868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a functionally active human hepatic UDP-glucuronosyltransferase (UGT1A6) lacking the N-terminal signal sequence in the endoplasmic reticulum.
    Ouzzine M; Magdalou J; Burchell B; Fournel-Gigleux S
    FEBS Lett; 1999 Jul; 454(3):187-91. PubMed ID: 10431804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes.
    Hanioka N; Takeda Y; Jinno H; Tanaka-Kagawa T; Naito S; Koeda A; Shimizu T; Nomura M; Narimatsu S
    Chem Biol Interact; 2006 Dec; 164(1-2):136-45. PubMed ID: 17027947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity.
    Müller S; Schöttler M; Schön S; Prante C; Brinkmann T; Kuhn J; Götting C; Kleesiek K
    Biochem J; 2005 Mar; 386(Pt 2):227-36. PubMed ID: 15461586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
    Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure/function of the human Ga1beta1,3-glucuronosyltransferase. Dimerization and functional activity are mediated by two crucial cysteine residues.
    Ouzzine M; Gulberti S; Netter P; Magdalou J; Fournel-Gigleux S
    J Biol Chem; 2000 Sep; 275(36):28254-60. PubMed ID: 10842173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
    Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of periodate-oxidized UDP-glucuronic acid with recombinant human liver UDP-glucuronosyltransferase 1A6.
    Battaglia E; Terrier N; Mizeracka M; Senay C; Magdalou J; Fournel-Gigleux S; Radominska-Pandya A
    Drug Metab Dispos; 1998 Aug; 26(8):812-7. PubMed ID: 9698297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
    Dubois SG; Beaulieu M; Lévesque E; Hum DW; Bélanger A
    J Mol Biol; 1999 May; 289(1):29-39. PubMed ID: 10339403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human UDP-glucuronosyltransferase: identification of key residues within the nucleotide-sugar binding site.
    Patana AS; Kurkela M; Goldman A; Finel M
    Mol Pharmacol; 2007 Sep; 72(3):604-11. PubMed ID: 17578897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine 52 and histidine 54 located in a conserved amino-terminal hydrophobic region (LX2-R52-G-H54-X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP-glucuronosyltransferase UGT1*6.
    Senay C; Ouzzine M; Battaglia E; Pless D; Cano V; Burchell B; Radominska A; Magdalou J; Fournel-Gigleux S
    Mol Pharmacol; 1997 Mar; 51(3):406-13. PubMed ID: 9058595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
    Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
    Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of critical structural elements of UDP-sugar substrates and certain cysteine residues of a vertebrate hyaluronan synthase.
    Pummill PE; DeAngelis PL
    J Biol Chem; 2002 Jun; 277(24):21610-6. PubMed ID: 11943783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
    Rowland A; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants.
    Benoit-Biancamano MO; Connelly J; Villeneuve L; Caron P; Guillemette C
    Drug Metab Dispos; 2009 Feb; 37(2):322-9. PubMed ID: 18971318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.